Literature DB >> 9569045

Endogenous antioxidant enzymes and glutathione S-transferase in protection of mesothelioma cells against hydrogen peroxide and epirubicin toxicity.

K Kinnula1, K Linnainmaa, K O Raivio, V L Kinnula.   

Abstract

We have previously shown that cultured malignant mesothelioma cells contain elevated manganese superoxide dismutase (MnSOD) mRNA levels and activities compared with non-malignant mesothelial cells. As many cytotoxic drugs generate both superoxide and hydrogen peroxide, we assessed the relative significance of catalase and the glutathione redox cycle, as well as glutathione S-transferase (GST), in protecting these cells against hydrogen peroxide and epirubicin toxicity. Mesothelioma cell lines containing high (M38K cells) and low (M14K cells) MnSOD, and non-malignant MeT-5A mesothelial cells were selected for the study. M38K cells were the most resistant of these three cell types to hydrogen peroxide (0.1-0.5 mM, 4 h) and epirubicin (0.1-0.5 microg ml(-1), 48 h) as judged by lactate dehydrogenase (LDH) release and by high-energy nucleotide (ATP, ADP, AMP) depletion. Total glutathione was higher in M38K cells (63.8 +/- 20.3 nnmol mg(-1) protein) than in M14K (25.2 +/- 8.2 nmol mg[-1]) or MeT-5A cells (23.5 +/- 4.5 nmol mg[-1]). Furthermore, GST specific activity was higher in M38K cells (111.3 +/- 15.8 U mg[-1]) than in M14K cells (77.4 +/- 6.6 U mg[-1]) or in MeT-5A cells (68.8 +/- 7.6 U mg[-1]). Western blotting indicated the presence of GST-pi in all these cells, the reactivity again being highest in M38K cells. Depletion of glutathione by buthionine sulphoximine and inhibition of catalase by aminotriazole enhanced hydrogen peroxide toxicity in all cell types, while only the depletion of glutathione increased epirubicin toxicity. We conclude that simultaneous induction of multiple antioxidant enzymes can occur in human mesothelioma cells. In addition to the high MnSOD activity, hydrogen peroxide scavenging antioxidant enzymes, glutathione and GST can partly explain the high hydrogen peroxide and epirubicin resistance of these cells in vitro.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9569045      PMCID: PMC2150125          DOI: 10.1038/bjc.1998.182

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  56 in total

1.  Irreversible reaction of 3-amino-1:2:4-triazole and related inhibitors with the protein of catalase.

Authors:  E MARGOLIASH; A NOVOGRODSKY; A SCHEJTER
Journal:  Biochem J       Date:  1960-02       Impact factor: 3.857

2.  Oxidants and antioxidants in alveolar epithelial type II cells: in situ, freshly isolated, and cultured cells.

Authors:  V L Kinnula; L Chang; J I Everitt; J D Crapo
Journal:  Am J Physiol       Date:  1992-01

3.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

4.  Manganese superoxide dismutase in human pleural mesothelioma cell lines.

Authors:  V L Kinnula; P Pietarinen-Runtti; K Raivio; K Kahlos; K Pelin; K Mattson; K Linnainmaa
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

5.  Assays for differentiation of glutathione S-transferases.

Authors:  W H Habig; W B Jakoby
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.

Authors:  X Cheng; J Kigawa; Y Minagawa; Y Kanamori; H Itamochi; M Okada; N Terakawa
Journal:  Cancer       Date:  1997-02-01       Impact factor: 6.860

7.  Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.

Authors:  M Müller; C Meijer; G J Zaman; P Borst; R J Scheper; N H Mulder; E G de Vries; P L Jansen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  Modulation of oxidant lung injury by using liposome-entrapped superoxide dismutase and catalase.

Authors:  B A Freeman; J F Turrens; Z Mirza; J D Crapo; S L Young
Journal:  Fed Proc       Date:  1985-07

9.  Alteration of superoxide dismutase activity in tracheal epithelial cells by asbestos and inhibition of cytotoxicity by antioxidants.

Authors:  B T Mossman; J P Marsh; M A Shatos
Journal:  Lab Invest       Date:  1986-02       Impact factor: 5.662

10.  The level of MnSOD is directly correlated with grade of brain tumours of neuroepithelial origin.

Authors:  M Landriscina; F Remiddi; F Ria; B Palazzotti; M E De Leo; M Iacoangeli; R Rosselli; M Scerrati; T Galeotti
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

View more
  5 in total

Review 1.  Drug resistance in lung cancer.

Authors:  Manish Shanker; David Willcutts; Jack A Roth; Rajagopal Ramesh
Journal:  Lung Cancer (Auckl)       Date:  2010-05-08

2.  Generation of reactive oxygen species by human mesothelioma cells.

Authors:  K Kahlos; S Pitkänen; I Hassinen; K Linnainmaa; V L Kinnula
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

Review 3.  Metabolic rewiring and redox alterations in malignant pleural mesothelioma.

Authors:  Loredana Urso; Ilaria Cavallari; Evgeniya Sharova; Francesco Ciccarese; Giulia Pasello; Vincenzo Ciminale
Journal:  Br J Cancer       Date:  2019-12-10       Impact factor: 7.640

4.  Sirtuin 3 enhanced drug sensitivity of human hepatoma cells through glutathione S-transferase pi 1/JNK signaling pathway.

Authors:  Na-Na Tao; Hong-Zhong Zhou; Hua Tang; Xue-Fei Cai; Wen-Lu Zhang; Ji-Hua Ren; Li Zhou; Xiang Chen; Ke Chen; Wan-Yu Li; Bo Liu; Qiu-Xia Yang; Sheng-Tao Cheng; Li-Xia Huang; Ai-Long Huang; Juan Chen
Journal:  Oncotarget       Date:  2016-08-02

Review 5.  Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role.

Authors:  Giuseppina Barrera; Marie Angele Cucci; Margherita Grattarola; Chiara Dianzani; Giuliana Muzio; Stefania Pizzimenti
Journal:  Antioxidants (Basel)       Date:  2021-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.